Drugs / Tongxinluo Capsule
Tongxinluo Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06061692 | Oct 2023 → Jun 2026 overdue | cerebrovascular disorder | Fudan University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tongxinluo Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06061692 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “through the application of traditional Chinese medicine” PMID 40935402 ↗ Apr 2026 |
| Route | Oral | “4 capsules/time, tid, p.o” NCT06061692 ↗ |